Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Jaye, M

Class:IdPerson:190937
_displayNameJaye, M
_timestamp2007-08-07 16:13:40
created[InstanceEdit:190940] de Bono, B, 2007-01-11 09:51:46
firstnameMichael
initialM
modified[InstanceEdit:201399] D'Eustachio, P, 2007-08-07 16:13:40
surnameJaye
(author)[LiteratureReference:190942] Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction
[LiteratureReference:191025] A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1
[LiteratureReference:201402] Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors
[LiteratureReference:1295588] Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis
[LiteratureReference:1301695] Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction
[LiteratureReference:1989699] PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
[LiteratureReference:9658265] Synthetic LXR agonists increase LDL in CETP species
[Change default viewing format]
No pathways have been reviewed or authored by Jaye, M (190937)
Follow Reactome